Rapid and quantitative automated measurement of bacteriophage activity against cystic fibrosis isolates of Pseudomonas aeruginosa

Journal of Applied Microbiology

Volumn 110, Issue 3, 2011, Pages 631-640

  Cooper, C J ^a   Denyer, S P ^a   Maillard, J Y ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bacteriophage; Lytic activity; Pseudomonas aeruginosa

Indexed keywords

BACTERIA; DIAGNOSIS; DISEASE CONTROL;

AERUGINOSA STRAINS; AUTOMATED MEASUREMENT; BIOSCREEN; CYSTIC FIBROSIS; LYTIC ACTIVITY; MEASUREMENTS OF; PS. AERUGINOSA; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ASSAY; THERAPEUTIC STRATEGY;

BACTERIOPHAGES;

POMEGRANATE EXTRACT;

ANTIBIOTICS; BACTERIAL DISEASE; BACTERIOPHAGE; BACTERIUM; INFECTIOUS DISEASE; INFECTIVITY; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; RESPIRATORY DISEASE;

ARTICLE; AUTOMATION; BACTERIOLYSIS; BACTERIOPHAGE; CYSTIC FIBROSIS; INCUBATION TEMPERATURE; INTERMETHOD COMPARISON; NONHUMAN; PSEUDOMONAS AERUGINOSA;

UNITED KINGDOM;

BACTERIA (MICROORGANISMS); LYTHRACEAE; PSEUDOMONAS AERUGINOSA;

EID: 79551673682     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2010.04928.x     Document Type: Article

References (25)

1. Adams, M.H. (1959) Bacteriophage. New York: Interscience Publishers Inc.
2. Armstrong, D., Bell, S., Robinson, M., Bye, P., Rose, B., Harbour, C., Lee, C., Service, H. et al. (2003) Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol 41, 2266-2267.
3. Atterbury, R.J., Van Bergen, M.A.P., Ortiz, F., Lovell, M.A., Harris, J.A., De Boer, A. et al. (2007) Bacteriophage therapy to reduce Salmonella colonization of broiler chickens. Appl Environ Microbiol 73, 4543-4549.
4. Cerca, N., Martins, S., Cerca, F., Jefferson, K.K., Pier, G.B., Oliveira, R. et al. (2005) Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 56, 331-336.
5. Edwards, K.J. and Saunders, N.A. (2001) Real-time PCR used to measure stress-induced changes in the expression of the genes of the alginate pathway of Pseudomonas aeruginosa. J Appl Microbiol 91, 29-37.
6. Fothergill, J.L., Panagea, S., Hart, C.A., Walshaw, M.J., Pitt, T.L. and Winstanley, C. (2007) Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol 7, 45-55.
7. Fu, W., Forster, T., Mayer, O., Curtin, J.J., Lehman, S.M. and Donlan, R.M. (2010) Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54, 397-404.
8. Hanlon, G.W. (2007) Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents 30, 118-128.
9. Hanlon, G.W., Denyer, S.P., Olliff, C.J. and Ibrahim, L.J. (2001) Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 67, 2746-2753.
10. Hart, S.L., Knight, A.M., Harbottle, R.P., Mistry, A., Hunger, H.D., Cutler, D.F. et al. (1994) Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J Biol Chem 269, 12468-12474.
11. Jassim, S.A.A. and Griffiths, M.W. (2007) Evaluation of a rapid microbial detection method via phage lytic amplification assay coupled with Live/Dead fluorochromic stains. Lett Appl Microbiol 44, 673-678.
12. Jassim, S.A., Denyer, S.P. and Stewart, G.S.A.B. (1995) Virus Breeding. International Patent Application, No. WO 9523848.
13. Jones, A.M., Govan, J.R.W., Doherty, C.J., Dodd, M.E., Isalska, B.J., Stanbridge, T.N. et al. (2001) Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358, 557-558.
14. Kuda, T. and Yano, T. (2003) Colorimetric alamarBlue assay as a bacterial concentration and spoilage index of marine foods. Food Control 14, 455-461.
15. Lewis, D.A., Jones, A., Parkhill, J., Speert, D.P., Govan, J.R., Lipuma, J.J. et al. (2005) Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain. Am J Respir Cell Mol Biol 33, 56-64.
16. Maillard, J.-Y., Beggs, T.S., Day, M.J., Hudson, R.A. and Russell, A.D. (1996) The use of an automated assay to assess phage survival after a biocidal treatment. J Appl Bacteriol 80, 605-610.
17. Marques, C.N.H., Salisbury, V.C., Greenman, J., Bowker, K.E. and Nelson, S.M. (2005) Discrepancy between viable counts and light output as viability measurements, following ciprofloxacin challenge of self-bioluminescent Pseudomonas aeruginosa biofilms. J Antimicrob Chemother 56, 665-671.
18. McCoy, K.S., Quittner, A.L., Oermann, C.M., Gibson, R.L., Retsch-Bogart, G.Z. and Montgomery, A.B. (2008) Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. Am J Respir Crit Care Med 178, 921-928.
19. Merabishvili, M., Pirnay, J.-P., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N. et al. (2009) Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE 4, e4944.
20. Saiman, L. and Siegel, J. (2004) Infection control in cystic fibrosis. Clin Microbiol Rev 17, 57-71.
21. Salunkhe, P., Smart, C.H.M., Morgan, J.A.W., Panagea, S., Walshaw, M.J., Hart, C.A. et al. (2005) A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 187, 4908-4920.
22. Stewart, G.S.A.B., Jassim, S.A.A., Denyer, S.P., Newby, P., Linley, K. and Dhir, V.K. (1998) The specific and sensitive detection of bacterial pathogens within 4h using bacteriophage amplification. J Appl Microbiol 84, 777-783.
23. Stover, C.K., Pham, X.Q., Erwin, A.L., Mizoguchi, S.D., Warrener, P., Hickey, M.J. et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406, 959-964.
24. Thorn, R.M.S., Nelson, S.M. and Greenman, J. (2007) Use of a bioluminescent Pseudomonas aeruginosa strain within an in vitro microbiological system, as a model of wound infection, to assess the antimicrobial efficacy of wound dressings by monitoring light production. Antimicrob Agents Chemother 51, 3217-3224.
25. Van Zanten, A.R.H., Oudijk, M., Nohlmans-Paulssen, M.K.E., van der Meer, Y.G., Girbes, A.R.J. and Polderman, K.H. (2007) Continuousvs.intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy. Br J Clin Pharmacol 63, 100-109.